Back

Cardiac resynchronization therapy: association between genetically determinated dilated cardiomyopathy and dissinchronopathy

28 August 2022 (11:40 - 11:50)
Organised by:
Congress Presentation Part of: Heart failure: let’s re-synchronise please Ventricular Remodelling ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Massimo Zecchin

Cattinara Hospital, Trieste (Italy)

5 More presentations in this session

Presentation thumbnail
Cardiac resynchronisation therapy and implantable cardioverter-defibrillator in non-ischaemic systolic heart failure: extended follow-up of the DANISH trial
Doctor A. Yafasova (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Impact of cardiac resynchronisation therapy in patients with cardiac sarcoidosis
Doctor R. Ahmed (Newcastle-Upon-Tyne, GB)
Abstract Slides Video
Presentation thumbnail
The impact of right ventricular size and function on long-term outcomes in patients undergoing cardiac resynchronization therapy
Mr X. Galloo (Brussels, BE)
Abstract Slides Video
Presentation thumbnail
Biventricular or left univentricular pacing in heart failure patients: is there a better strategy
Doctor M. Barradas (Ponta Delgada, PT)
Abstract Slides Video
Presentation thumbnail
Prediction of response to cardiac resynchronization therapy using cardiac magnetic resonance imaging in non-ischemic dilated cardiomyopathy
Doctor S. Kim (Seoul, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Heart failure: let’s re-synchronise please

The Event

Event poster

ESC Congress 2022

28 August 2022 11:40 CET
You may be interested in
thumbnail
Congress Presentation
The impact of desmosomal mutations on clinical features in arrhythmogenic cardiomyopathy: towards tailored arrhythmic risk stratification
thumbnail
Congress Presentation
Predictors of the identification of clinically relevant genetic variants in dilated cardiomyopathy in a sample of the brazilian population
thumbnail
Congress Presentation
Management of ventricular arrhythmias in left ventricular cardiomyopathy: aetiology matters

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources